DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
(Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | (Q1)Mar 31, 2016 | (FY)Dec 31, 2015 | (Q4)Dec 31, 2015 | (Q3)Sep 30, 2015 | (Q2)Jun 30, 2015 | (Q1)Mar 31, 2015 | (FY)Dec 31, 2014 | (Q4)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 32.57%-523.22K | 41.40%-384.22K | -30.59%-669.35K | 4.11%-2.26M | 26.38%-314.46K | -16.66%-775.93K | -8.68%-655.61K | 22.32%-512.56K | -39.43%-2.36M | -386.43%-427.16K |
Net income from continuing operations | ---- | ---- | ---- | -3.19%-3.89M | ---- | ---- | ---- | ---- | -30.80%-3.77M | ---- |
Depreciation and amortization | ---- | ---- | ---- | 32.80%579.33K | ---- | ---- | ---- | ---- | 73.96%436.23K | ---- |
Other non cash items | ---- | ---- | ---- | -51.73%33.33K | ---- | ---- | ---- | ---- | -56.19%69.06K | ---- |
Change In working capital | ---- | ---- | ---- | -31.52%176.01K | ---- | ---- | ---- | ---- | 172.28%257.03K | ---- |
-Change in inventory | ---- | ---- | ---- | 16.18%-27.27K | ---- | ---- | ---- | ---- | -3.08%-32.53K | ---- |
-Change in prepaid assets | ---- | ---- | ---- | -122.77%-51.48K | ---- | ---- | ---- | ---- | 436.89%226.05K | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | 1,342.94%287.95K | ---- | ---- | ---- | ---- | 105.42%19.96K | ---- |
-Change in other working capital | ---- | ---- | ---- | -176.24%-33.21K | ---- | ---- | ---- | ---- | 1,765.35%43.56K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 32.57%-523.22K | 41.40%-384.22K | -30.59%-669.35K | 4.11%-2.26M | 26.38%-314.46K | -16.66%-775.93K | -8.68%-655.61K | 22.32%-512.56K | -39.43%-2.36M | -386.43%-427.16K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 87.50%-40.11K | 99.25%-4.2K | 98.43%-11.36K | -478.16%-1.87M | -264.84%-263.21K | -568.95%-320.75K | -1,256.36%-558.18K | -210.71%-725.23K | 139.88%493.8K | -373.81%-72.14K |
Net PPE purchase and sale | 87.50%-40.11K | 99.25%-4.2K | 98.43%-11.36K | -432.36%-1.87M | -462.30%-263.21K | -568.95%-320.75K | -1,256.36%-558.18K | -237.54%-725.23K | 71.67%-350.77K | -207.43%-46.81K |
Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --869.91K | --0 |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---25.33K | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 87.50%-40.11K | 99.25%-4.2K | 98.43%-11.36K | -478.16%-1.87M | -264.84%-263.21K | -568.95%-320.75K | -1,256.36%-558.18K | -210.71%-725.23K | 139.88%493.8K | -373.81%-72.14K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -59.41%518.38K | -79.02%239.18K | -133.44%-166.61K | 33.70%4.05M | -28.89%1.14M | 111.00%1.28M | 106.37%1.14M | 81.19%498.27K | 53.12%3.03M | 2,076.57%1.6M |
Net issuance payments of debt | 244.70%344.7K | -35.35%87.2K | -236.44%-437.8K | -75.33%437.92K | -108.51%-117.85K | -74.36%100K | --134.89K | --320.88K | 338.35%1.77M | 1,786.84%1.38M |
Net common stock issuance | -71.12%213K | -53.02%191.36K | 47.89%232.76K | 114.08%2.69M | 551.10%1.38M | 243.02%737.5K | -26.26%407.28K | -42.77%157.39K | -6.56%1.25M | --212.61K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | -92.92%25 | --0 | ---- | ---- | ---- | -92.91%353 | --28 |
Net other financing activities | -108.95%-39.37K | -106.59%-39.38K | 92.19%38.44K | --926.71K | ---130.63K | --439.71K | --597.63K | --20K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -59.41%518.38K | -79.02%239.18K | -133.44%-166.61K | 33.70%4.05M | -28.89%1.14M | 111.00%1.28M | 106.37%1.14M | 81.19%498.27K | 53.12%3.03M | 2,076.57%1.6M |
Net cash flow | ||||||||||
Beginning cash position | -69.95%110.77K | -41.25%260.01K | -6.33%1.11M | 8,584.88%1.18M | 553.79%549.14K | 92.26%368.59K | 55.95%442.58K | 8,584.88%1.18M | -98.59%13.61K | 94.15%83.99K |
Current changes in cash | -124.90%-44.95K | -101.69%-149.24K | -14.58%-847.32K | -106.40%-74.77K | -49.17%558.19K | 267.62%180.55K | 19.64%-73.99K | -373.72%-739.52K | 223.16%1.17M | 3,803.56%1.1M |
End cash Position | -88.01%65.82K | -69.95%110.77K | -41.25%260.01K | -6.33%1.11M | -6.33%1.11M | 553.79%549.14K | 92.26%368.59K | 55.95%442.58K | 8,584.88%1.18M | 8,584.88%1.18M |
Free cash flow | 48.63%-563.33K | 68.00%-388.42K | 45.01%-680.72K | -52.47%-4.13M | -21.88%-577.67K | -53.80%-1.1M | -88.37%-1.21M | -41.51%-1.24M | 7.56%-2.71M | -359.98%-473.97K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |